This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1976 Feb;116(2):568-70.

Isolation of alternative pathway C3 convertase containing uncleaved B and formed in the presence of C3 nephritic factor (C3neF)

M R Daha, D T Fearon, K F Austen

PMID: 1249423

Isolation of alternative pathway C3 convertase containing uncleaved B and formed in the presence of C3 nephritic factor (C3neF)

M R Daha et al. J Immunol. 1976 Feb.

. 1976 Feb;116(2):568-70.

Authors

M R Daha, D T Fearon, K F Austen

PMID: 1249423

No abstract available

PubMed Disclaimer

Similar articles

Formation in the presence of C3 nephritic factor (C3NeF) of an alternative pathway C3 convertase containing uncleaved B.
Daha MR, Fearon DT, Austen KF. Daha MR, et al. Immunology. 1976 Nov;31(5):789-96. Immunology. 1976. PMID: 992711 Free PMC article.
C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.
Daha MR, Fearon DT, Austen KF. Daha MR, et al. J Immunol. 1976 Jan;116(1):1-7. J Immunol. 1976. PMID: 1245733
Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
Hiramatsu M, Balow JE, Tsokos GC. Hiramatsu M, et al. J Immunol. 1986 Jun 15;136(12):4451-5. J Immunol. 1986. PMID: 3011894
[Role of the C3 nephritic factor in the pathogenesis of glomerulonephritis].
Belovezhov N, Neshev Kh. Belovezhov N, et al. Vutr Boles. 1978;17(1):9-12. Vutr Boles. 1978. PMID: 349880 Review. Bulgarian. No abstract available.
Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
Licht C, Fremeaux-Bacchi V. Licht C, et al. Thromb Haemost. 2009 Feb;101(2):271-8. Thromb Haemost. 2009. PMID: 19190809 Review.

See all similar articles

Cited by

Metabolism of the fifth component of complement, and its relation to metabolism of the third component, in patients with complement activation.
Sissons JG, Liebowitch J, Amos N, Peters DK. Sissons JG, et al. J Clin Invest. 1977 Apr;59(4):704-15. doi: 10.1172/JCI108689. J Clin Invest. 1977. PMID: 845257 Free PMC article.
Modulation of the formation of the human amplification C3 convertase of complement by polycations.
Maillet F, Kazatchkine MD. Maillet F, et al. Immunology. 1983 Sep;50(1):27-33. Immunology. 1983. PMID: 6554235 Free PMC article.
Formation in the presence of C3 nephritic factor (C3NeF) of an alternative pathway C3 convertase containing uncleaved B.
Daha MR, Fearon DT, Austen KF. Daha MR, et al. Immunology. 1976 Nov;31(5):789-96. Immunology. 1976. PMID: 992711 Free PMC article.
Mechanism of action of factor D of the alternative complement pathway.
Lesavre PH, Müller-Eberhard HJ. Lesavre PH, et al. J Exp Med. 1978 Dec 1;148(6):1498-509. doi: 10.1084/jem.148.6.1498. J Exp Med. 1978. PMID: 82604 Free PMC article.
Complement activation in factor D-deficient mice.
Xu Y, Ma M, Ippolito GC, Schroeder HW Jr, Carroll MC, Volanakis JE. Xu Y, et al. Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14577-82. doi: 10.1073/pnas.261428398. Epub 2001 Nov 27. Proc Natl Acad Sci U S A. 2001. PMID: 11724962 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Miscellaneous
- NCI CPTAC Assay Portal